Truck driver Oswaldo Monroy, 62, was tested for COVID-19 at an International Brotherhood of Teamsters test site, as the spread of coronavirus (COVID-19) continued, in Wilmington, near the Port of Los Angeles, California, June 25, 2020.
Lucy Nicholson | Reuters
The Food and Drug Administration on Friday announced that it has authorized the first serological test to screen for antibodies that were neutralized by previous coronavirus infection.
Neutralizing antibodies prevent the virus from infecting cells, although questions remain about the lifetime of antibodies against Covid-19 and the level of protection they provide. Dr. Tim Stenzel, director of the Office of In vitro Diagnosis and Radiation Health at FDA’s Center for Radioactive Health and Equipment, said the new serological test will help researchers study the resistance. neutral form.
“The ability to detect neutralizing antibodies may help us understand more about the meaning of the existence of antibodies to the patient as we continue our fight against COVID,” he said in a statement. 19. “There is still much unknown about the presence of SARS-CoV-2 antibodies that may tell us about immunity, but delegating today gives us another tool to evaluate those antibodies as we continue to study and study this virus. “
Patients and healthcare providers should not explain that a positive result of the test means the patient is protected against Covid-19, the agency said. The FDA says it should still follow the public health precautions.
FDA has granted emergency use licenses to GenScript USA, the test production company.